Transcription factor binding site affinity and the link to phenotype

Michael Fletcher

DOI: https://doi.org/10.1038/s41588-024-01697-8

IF: 30.8

2024-03-15

Nature Genetics

Abstract:Genetic variation, such as single-nucleotide variants (SNVs), can alter transcription factor binding and thus phenotypes. However, the exact mechanistic bases of this process remain poorly understood. Lim et al. examine the classic model enhancer, ZRS, which regulates expression of SHH during limb development and contains SNVs that are causal for polydactyly. Using protein-binding microarray data, the authors found that the ETS sites within the ZRS are low affinity, whereas polydactyly-associated SNVs have higher binding affinity. Introduction of a gain-of-function, affinity-optimizing synthetic SNV phenocopies known polydactyly-associated SNVs in mouse models with equal penetrance; further increasing the affinity of the ETS site leads to a more severe and penetrant phenotype. Published massively parallel reporter assay data for ZRS and other enhancers recapitulate the broad trend of increasing affinity leading to a gain of function of gene expression, although affinity-optimizing SNVs are a small fraction of those tested. The authors conclude that incorporating such biochemical properties may assist in identifying causal variation. As ZRS and other enhancers have multiple binding sites bound by combinations of transcription factors, it is likely that such biochemical interactions within an enhancer between transcription factors, their cognate binding sites, as well as with the other enhancers of a gene, all contribute to the complexity of gene regulation. Original reference: Nature 626 , 151–159 (2024)

genetics & heredity